Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.45 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.44 |
| ▸ | PTGES | O14684 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL914300 | 1.00 | CA4 (0.45) | CA4HSD17B2HSD17B1MTNR1AMTNR1B | |
| SCHEMBL19275026 | 1.00 | CA4 (0.45) | CA4HSD17B2HSD17B1MTNR1AMTNR1B | |
| SCHEMBL9763422 | 0.98 | HSD17B2 (0.47) | CA4HSD17B2HSD17B1MTNR1AMTNR1B | |
| SCHEMBL13136850 | 0.98 | HSD17B2 (0.47) | CA4HSD17B2HSD17B1MTNR1AMTNR1B | |
| SCHEMBL12463079 | 0.98 | HSD17B2 (0.47) | CA4HSD17B2HSD17B1MTNR1AMTNR1B | |
| SCHEMBL3442214 | 0.98 | HSD17B2 (0.47) | CA4HSD17B2HSD17B1MTNR1AMTNR1B | |
| SCHEMBL17372968 | 0.98 | HSD17B2 (0.47) | CA4HSD17B2HSD17B1MTNR1AMTNR1B | |
| SCHEMBL4324691 | 0.98 | HSD17B2 (0.47) | CA4HSD17B2HSD17B1MTNR1AMTNR1B | |
| SCHEMBL9770735 | 0.96 | HSD17B2 (0.47) | HSD17B2HSD17B1MTNR1AMTNR1BALOX15 | |
| SCHEMBL10065629 | 0.94 | CA4 (0.50) | CA4HSD17B2HSD17B1MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2726460-B1 | COMPOUNDS FOR THE TREATMENT OF ADDICTION | GILEAD SCIENCES INC (US) | 2015-09-23 | — | — | EP | claimed |
| EP-2621713-B1 | DEVICE AND METHOD FOR THE PRODUCTION OF 3D STRUCTURES IN LAYERS, AND USE THEREOF | FRAUNHOFER GES FORSCHUNG (DE) | 2015-09-23 | — | — | EP | claimed |
| US-20090131721-A1 | METHOD OF DEPROTECTION OF ALKYL ARYLAMINE ETHERS | XEROX CORPORATION (US) | 2009-05-21 | — | — | US | claimed |
| US-5863686-A | ELECTROPHOTOGRAPHIC IMAGING PLATE COMPRISING A CHARGE GENERATING LAYER WITH DISPERSED PHOTOCONDUCTIVE PIGMENT PARTICLES, A CHARGE TRANSPORT LAYER AND A SUBSTRATE; IMPROVING SENSITIVITY | XEROX CORPORATION (US) | 1999-01-26 | — | — | US | claimed |
| US-20200388791-A1 | ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING CAPPING LAYER AND USE | VALIANT CO., LTD. | 2020-12-10 | — | — | US | disclosed |
| CN-109980085-A | A kind of Organnic electroluminescent device and purposes containing coating | 江苏三月光电科技有限公司 | 2019-07-05 | — | — | CN | disclosed |
| EP-3057152-B1 | OLEDS HAVING INORGANIC MATERIAL CONTAINING ANODE CAPPING LAYER | LG DISPLAY CO LTD (KR) | 2018-10-17 | — | — | EP | disclosed |
| EP-1624504-B1 | OLEDs having inorganic material containing anode capping layer | LG DISPLAY CO LTD (KR) | 2016-10-12 | — | — | EP | disclosed |
| EP-1763087-B1 | PHOTOELECTRIC CONVERSION DEVICES | ADEKA CORP (JP) | 2016-08-03 | — | — | EP | disclosed |
| EP-1385221-B1 | Display device with anthracene and triazine derivtives | LG DISPLAY CO LTD (KR) | 2015-12-02 | — | — | EP | disclosed |
| EP-2726460-B1 | COMPOUNDS FOR THE TREATMENT OF ADDICTION | GILEAD SCIENCES INC (US) | 2015-09-23 | — | — | EP | disclosed |
| EP-2621713-B1 | DEVICE AND METHOD FOR THE PRODUCTION OF 3D STRUCTURES IN LAYERS, AND USE THEREOF | FRAUNHOFER GES FORSCHUNG (DE) | 2015-09-23 | — | — | EP | disclosed |
| EP-0314195-A2 | Electrophotographic sensitive material | MITA INDUSTRIAL CO. LTD. (JP) | 1989-05-03 | — | — | EP | disclosed |
| US-4818650-A | Arylamine containing polyhydroxy ether resins and system utilizing arylamine containing polyhydroxyl ether resins | XEROX CORPORATION (US) | 1989-04-04 | — | — | US | disclosed |
| US-4806443-A | Polyarylamine compounds and systems utilizing polyarylamine compounds | XEROX CORPORATION (US) | 1989-02-21 | — | — | US | disclosed |
| US-4806444-A | Arylamine polymers and systems utilizing arylamine polymers | XEROX CORPORATION (US) | 1989-02-21 | — | — | US | disclosed |
| EP-0295127-A2 | Arylamine polymers | XEROX CORPORATION (US) | 1988-12-14 | — | — | EP | disclosed |
| EP-0295115-A2 | Arylamine compounds | XEROX CORPORATION (US) | 1988-12-14 | — | — | EP | disclosed |
| EP-0295125-A2 | Polyarylamine compounds | XEROX CORPORATION (US) | 1988-12-14 | — | — | EP | disclosed |
| EP-0295126-A2 | Arylamine-containing polyhydroxy ether resins | XEROX CORPORATION (US) | 1988-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131721-A1 | METHOD OF DEPROTECTION OF ALKYL ARYLAMINE ETHERS | NAT1, PNMT, AADAC | CA4 3488/4885HSD17B2 285/4885HSD17B1 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.